Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

From Animal Poisons and Venoms to Medicines: Achievements, Challenges and Perspectives in Drug Discovery
Karla de Castro Figueiredo Bordon, Camila Takeno Cologna, Elisa Corrêa Fornari-Baldo, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 227

Showing 1-25 of 227 citing articles:

The chemistry of snake venom and its medicinal potential
Ana Oliveira, Matilde F. Viegas, Saulo L. da Silva, et al.
Nature Reviews Chemistry (2022) Vol. 6, Iss. 7, pp. 451-469
Open Access | Times Cited: 163
Modern venomics—Current insights, novel methods, and future perspectives in biological and applied animal venom research
Björn M. von Reumont, Gregor Anderluh, Agostinho Antunes, et al.
GigaScience (2022) Vol. 11
Open Access | Times Cited: 70
Deep-STP: a deep learning-based approach to predict snake toxin proteins by using word embeddings
Hasan Zulfiqar, Zhiling Guo, Ramala Masood Ahmad, et al.
Frontiers in Medicine (2024) Vol. 10
Open Access | Times Cited: 55
Bee Venom: Composition and Anticancer Properties
Goran Gajski, Elīna Ļeonova, Nikolajs Sjakste
Toxins (2024) Vol. 16, Iss. 3, pp. 117-117
Open Access | Times Cited: 16
Cellular Nanosponges for Biological Neutralization
Shuyan Wang, Dan Wang, Yaou Duan, et al.
Advanced Materials (2021) Vol. 34, Iss. 13
Open Access | Times Cited: 67
Future directions for the discovery of natural product-derived immunomodulating drugs: an IUPHAR positional review
Cherry L. Wainwright, Mauro Martins Teixeira, David L. Adelson, et al.
Pharmacological Research (2022) Vol. 177, pp. 106076-106076
Open Access | Times Cited: 53
Potassium Channels as a Target for Cancer Therapy: Current Perspectives
Leandro Zúñiga, Ángel Cayo, Wendy González, et al.
OncoTargets and Therapy (2022) Vol. Volume 15, pp. 783-797
Open Access | Times Cited: 45
Genetic variability in snake venom and its implications for antivenom development in sub-Saharan Africa
Innocent Ayesiga, Lenz Nwachinemere Okoro, Chirigo Taremba, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene (2025)
Closed Access | Times Cited: 1
MjTX-II, a Lys49-PLA2 from Bothrops moojeni snake venom, restricts Toxoplasma gondii infection via ROS and VEGF regulation
Samuel Cota Teixeira, Thales Alves de Melo Fernandes, Guilherme de Souza, et al.
Chemico-Biological Interactions (2025), pp. 111417-111417
Closed Access | Times Cited: 1
Snake Venom Components: Tools and Cures to Target Cardiovascular Diseases
Jacinthe Frangieh, Mohamad Rima, Ziad Fajloun, et al.
Molecules (2021) Vol. 26, Iss. 8, pp. 2223-2223
Open Access | Times Cited: 44
Scorpion species of medical importance in the Brazilian Amazon: a review to identify knowledge gaps
Jonas Gama Martins, Gabrielle Cristina Santos, Rudi Emerson de Lima Procópio, et al.
˜The œJournal of venomous animals and toxins including tropical diseases (2021) Vol. 27
Open Access | Times Cited: 43
A cyclic heptapeptide-based hydrogel boosts the healing of chronic skin wounds in diabetic mice and patients
Zhe Fu, Huiling Sun, Yutong Wu, et al.
NPG Asia Materials (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 37
Strategies for Heterologous Expression, Synthesis, and Purification of Animal Venom Toxins
Esperanza Rivera‐de‐Torre, Charlotte Rimbault, Timothy P. Jenkins, et al.
Frontiers in Bioengineering and Biotechnology (2022) Vol. 9
Open Access | Times Cited: 34
Scorpion venom peptides: Molecular diversity, structural characteristics, and therapeutic use from channelopathies to viral infections and cancers
Zhiqiang Xia, Dangui He, Yingliang Wu, et al.
Pharmacological Research (2023) Vol. 197, pp. 106978-106978
Open Access | Times Cited: 20
Snake venom toxins: Potential anticancer therapeutics
Benedict C. Offor, Lizelle A. Piater
Journal of Applied Toxicology (2023) Vol. 44, Iss. 5, pp. 666-685
Open Access | Times Cited: 17
Peptides from Marine-Derived Fungi: Chemistry and Biological Activities
Salar Hafez Ghoran, Fatemeh Taktaz, Emı́lia Sousa, et al.
Marine Drugs (2023) Vol. 21, Iss. 10, pp. 510-510
Open Access | Times Cited: 17
Therapeutic applications of snake venoms: An invaluable potential of new drug candidates
Rafaela Diniz‐Sousa, Cleópatra Alves da Silva Caldeira, Soraya dos Santos Pereira, et al.
International Journal of Biological Macromolecules (2023) Vol. 238, pp. 124357-124357
Closed Access | Times Cited: 16
Climate change-related distributional range shifts of venomous snakes: a predictive modelling study of effects on public health and biodiversity
Pablo A. Martínez, Irene Barbosa da Fonseca Teixeira, Tuany Siqueira‐Silva, et al.
The Lancet Planetary Health (2024) Vol. 8, Iss. 3, pp. e163-e171
Open Access | Times Cited: 7
A review on inflammation modulating venom proteins/peptide therapeutics and their delivery strategies: A review
Lakshmikanthan Hemajha, Simran Singh, Catherin Ann Biji, et al.
International Immunopharmacology (2024) Vol. 142, pp. 113130-113130
Closed Access | Times Cited: 6
Treatment of Chronic Venous Ulcers With Heterologous Fibrin Sealant: A Phase I/II Clinical Trial
Luciana Patrícia Fernandes Abbade, Sílvia Regina Catharino Sartori Barraviera, Maria Regina Cavariani Silvares, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 35
Therapeutic Potential of Peptides Derived from Animal Venoms: Current Views and Emerging Drugs for Diabetes
Aimee Coulter‐Parkhill, Stephen McClean, Victor A. Gault, et al.
Clinical Medicine Insights Endocrinology and Diabetes (2021) Vol. 14
Open Access | Times Cited: 35
Discovery of KV1.3 ion channel inhibitors: Medicinal chemistry approaches and challenges
Špela Gubič, Louise Antonia Hendrickx, Žan Toplak, et al.
Medicinal Research Reviews (2021) Vol. 41, Iss. 4, pp. 2423-2473
Open Access | Times Cited: 33
Peptide Shuttles for Blood–Brain Barrier Drug Delivery
Macarena Sánchez‐Navarro, Ernest Giralt
Pharmaceutics (2022) Vol. 14, Iss. 9, pp. 1874-1874
Open Access | Times Cited: 25
Purification and characterization of a novel thermostable anticoagulant protein from medicinal leech Whitmania pigra Whitman
Yajie Zhang, Rong Yang, Liwei Wang, et al.
Journal of Ethnopharmacology (2022) Vol. 288, pp. 114990-114990
Closed Access | Times Cited: 24
Progress and Impact of Latin American Natural Product Databases
Alejandro Gómez‐García, José L. Medina‐Franco
Biomolecules (2022) Vol. 12, Iss. 9, pp. 1202-1202
Open Access | Times Cited: 24
Page 1 - Next Page

Scroll to top